These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 18790771
1. Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer. Kawata E, Ashihara E, Kimura S, Takenaka K, Sato K, Tanaka R, Yokota A, Kamitsuji Y, Takeuchi M, Kuroda J, Tanaka F, Yoshikawa T, Maekawa T. Mol Cancer Ther; 2008 Sep; 7(9):2904-12. PubMed ID: 18790771 [Abstract] [Full Text] [Related]
6. A combination of a DNA-chimera siRNA against PLK-1 and zoledronic acid suppresses the growth of malignant mesothelioma cells in vitro. Kawata E, Ashihara E, Nakagawa Y, Kiuchi T, Ogura M, Yao H, Sakai K, Tanaka R, Nagao R, Yokota A, Takeuchi M, Kimura S, Hirai H, Maekawa T. Cancer Lett; 2010 Aug 28; 294(2):245-53. PubMed ID: 20206440 [Abstract] [Full Text] [Related]
9. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression. Kronschnabl P, Grünweller A, Hartmann RK, Aigner A, Weirauch U. Int J Oncol; 2020 Feb 28; 56(2):448-459. PubMed ID: 31894300 [Abstract] [Full Text] [Related]
10. Atelocollagen-mediated intravenous siRNA delivery specific to tumor tissues orthotopically xenografted in prostates of nude mice and its anticancer effects. Yuan Y, Makita N, Cao D, Mihara K, Kadomatsu K, Takei Y. Nucleic Acid Ther; 2015 Apr 28; 25(2):85-94. PubMed ID: 25692652 [Abstract] [Full Text] [Related]
12. Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. Takeshita F, Minakuchi Y, Nagahara S, Honma K, Sasaki H, Hirai K, Teratani T, Namatame N, Yamamoto Y, Hanai K, Kato T, Sano A, Ochiya T. Proc Natl Acad Sci U S A; 2005 Aug 23; 102(34):12177-82. PubMed ID: 16091473 [Abstract] [Full Text] [Related]
13. Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo. Minakuchi Y, Takeshita F, Kosaka N, Sasaki H, Yamamoto Y, Kouno M, Honma K, Nagahara S, Hanai K, Sano A, Kato T, Terada M, Ochiya T. Nucleic Acids Res; 2004 Jul 22; 32(13):e109. PubMed ID: 15272050 [Abstract] [Full Text] [Related]
14. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform. Shi M, Zhang J, Huang Z, Chen Y, Pan S, Hu H, Qiao M, Chen D, Zhao X. J Mater Chem B; 2020 Feb 26; 8(8):1616-1628. PubMed ID: 32010914 [Abstract] [Full Text] [Related]
15. BI 6727, a Polo-like kinase inhibitor with improved pharmacokinetic profile and broad antitumor activity. Rudolph D, Steegmaier M, Hoffmann M, Grauert M, Baum A, Quant J, Haslinger C, Garin-Chesa P, Adolf GR. Clin Cancer Res; 2009 May 01; 15(9):3094-102. PubMed ID: 19383823 [Abstract] [Full Text] [Related]
17. Intravenous liposomal delivery of the short hairpin RNAs against Plk1 controls the growth of established human hepatocellular carcinoma. Deng H, Jiang Q, Yang Y, Zhang S, Ma Y, Xie G, Chen X, Qian Z, Wen Y, Li J, Yang J, Chen L, Zhao X, Wei Y. Cancer Biol Ther; 2011 Feb 15; 11(4):401-9. PubMed ID: 21150280 [Abstract] [Full Text] [Related]
18. Inhibition of Plk1 and Pin1 by 5'-nitro-indirubinoxime suppresses human lung cancer cells. Yoon HE, Kim SA, Choi HS, Ahn MY, Yoon JH, Ahn SG. Cancer Lett; 2012 Mar 15; 316(1):97-104. PubMed ID: 22115795 [Abstract] [Full Text] [Related]
20. Polo-like kinase 1 inhibitor BI 6727 induces DNA damage and exerts strong antitumor activity in small cell lung cancer. Wang Y, Wu L, Yao Y, Lu G, Xu L, Zhou J. Cancer Lett; 2018 Nov 01; 436():1-9. PubMed ID: 30118839 [Abstract] [Full Text] [Related] Page: [Next] [New Search]